You are Here : Ranbaxy Q2 revenues seen up 30% to Rs 2,727 cr

Thursday, 07:48

Pharmaceutical company Ranbaxy Labs' revenues are seen going up by 30% YoY to Rs 2,727 crore and earnings before interest, tax, depreciation and amortisation (EBITDA) are expected to go up by 117% YoY to Rs 395 crore in the April-June quarter.
SEP 26, 2017
09:32 AM

cnbc tv18 shows

All Shows

mytv on mobile

Track your portfolio on the go with

moneycontrol app

Follow us on
Available On